Telemedicine is rewriting the rules of care delivery.
The pandemic has disrupted the way doctors care for their patients, especially for ob/gyns. Virtual visits and telehealth appointments have become more common and have actually become the preferred method of care delivery for many patients. In fact, research shows that patients prefer them, as they are more likely to adhere to prescription intake and wellness recommendations.
Related: Guide to effective virtual visits
In a recent article, Medical Economics explored the journey toward telehealth, and how the virtual visit has come to be the preferred method of care for doctors and patients alike.
“For those who have labeled telemedicine a ‘pandemic fad,’ the data is not on your side. 83% of patients plan to use telemedicine after COVID-19 no longer presents a worldwide emergency,” the article stated.
Surge of antidepressant use seen among female adolescents during COVID-19
March 7th 2024A study revealed a significant increase in antidepressant prescriptions among adolescents and young adults during the COVID-19 pandemic, particularly among female adolescents, indicating exacerbation of pre-existing mental health challenges.
Read More
Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.
Listen
COVID-19 vaccination during pregnancy not linked to preterm birth
January 31st 2024A systematic review of 6 studies revealed that COVID-19 vaccination during pregnancy does not significantly increase the risk of preterm birth, providing crucial insights for public health policies and offering reassurance to healthcare providers and expectant mothers.
Read More
Maternal COVID-19 vaccination deemed safe for infant neurodevelopment up to 18 months
January 23rd 2024A recent study found that in utero exposure to maternal COVID-19 vaccination poses no increased risk for neurodevelopmental impairment in infants up to 18 months of age, addressing concerns about the impact of vaccine exposure on unborn children.
Read More